UiPath (PATH.US) 2026财年第四季度及全年业绩电话会
文章语言:
简
繁
EN
Share
Minutes
原文
会议摘要
UiPath leverages AI and agentic automation to enhance its platform, drive customer adoption, and achieve significant financial milestones, including GAAP profitability and a non-GAAP operating margin of 31%, with guidance for continued ARR growth in fiscal 2027.
会议速览
UiPath achieved record ARR growth to $1.853B, $481M revenue, and posted its strongest Q4 customer net additions, marking the first full-year GAAP profitability and a 31% non-GAAP operating margin.
AI advancements lower software creation costs, shifting value towards governance and orchestration platforms. As more software is built, the need for enterprise orchestration grows, highlighting the importance of reliable, secure, and accountable systems management.
Uipath's comprehensive platform, combining deterministic and AI automation, secures enterprise trust and scalability. By orchestrating workflows with governance, it accelerates AI deployment, evidenced by significant cost savings and operational efficiency improvements for global clients. The installed base flywheel effect amplifies platform adoption, with AI products becoming central to major customer roadmaps, driving platform-wide expansion.
Uipath's Test Cloud and enterprise-grade governance stand out in autonomous testing, chosen by clients for meeting strict security and compliance. Vertical depth and domain-specific intelligence are critical for scalable operations and real impact in the AI era.
The company launches genetic AI solutions for healthcare, acquires Work Fusion for financial compliance, and partners with Deloitte and Accenture for ERP and sales order automation. AI coding agents streamline automation backlogs, enhancing ROI and executive support. Anticipating $2 billion ARR, the firm invites participation in the annual A Summit.
Highlights operational improvements, including sales and customer service alignment, AI integration, and efficiency gains. Announces fiscal 2026 non-GAAP operating margin of 23%, exceeding initial targets. Projects fiscal 2027 non-GAAP margin target increase to Que, alongside GAAP profitability focus. Discusses revenue growth, FX impacts, and strategic priorities for customer base expansion and vertical market penetration.
UiPath reports a significant increase in ARR, with a strong focus on AI product adoption, achieving record financial results including profitability and a 31% non-GAAP operating margin. The company emphasizes cloud migration, customer retention, and expansion, with a strategic commitment to disciplined capital allocation and share repurchases.
The company shared its financial guidance for Q1 and FY27, highlighting revenue and ARR ranges, non-GAAP operating income, and a 1% SaaS growth headwind. It emphasized Work Fusion's contribution, macroeconomic factors, and committed to managing stock-based compensation, aiming for 2-3% dilution YoY.
Instructions are given on how to join and manage participation in a 30-minute question and answer session via telephone, including queuing and removal from the queue.
The dialogue focuses on the impact of foreign exchange on net new annual recurring revenue (ARR), strategies for margin expansion including technology investments, and the immaterial contribution of the Work Fusion acquisition to overall financial guidance. It highlights the company's balanced approach to growth and margin targets, emphasizing the integration of AI technologies within their offerings.
The dialogue highlights the positive traction and strong positioning within the federal government, emphasizing the team's high-level connections and the increased appetite for long-term strategic projects, particularly in the Department of War.
Discusses the integration of AI and automation technologies, emphasizing strengths in public sector and specific markets, while addressing economic variability and guidance philosophy.
The guidance provided reflects stabilization in net new ARR, leveraging strong statistical models and macroeconomic prudence. The approach integrates field insights, financial forecasting, and operational data to account for market variability, highlighting the team's traction in the agentic market.
The dialogue highlights healthcare and finance as key verticals with strong spending on AI initiatives, also noting public sector as emerging. Maestro platform's agnosticism towards managing various agents is discussed, emphasizing its capability to integrate open-source frameworks and facilitate use of system-record applications, while maintaining security and governance.
The dialogue highlights how AI is revitalizing interest in automation, with AI and deterministic automation proving complementary. The discussion emphasizes the success of AI products in expanding customer adoption, their synergy with core RPA, and the potential of test automation as a growth driver. Metrics show strong AI product integration among large customers, indicating its pivotal role in future growth strategies.
Discussion highlights the company's strategic focus on vertical solutions, process orchestration, and AI agents, with successful sales execution as the primary driver of quarterly results, amidst minimal impact from fluctuating FX rates.
The dialogue highlights how integrating AI with deterministic automations enhances customer renewals and expands automation capabilities, with early success in deploying screen agents for complex workflows. It discusses the conservative ARR guidance methodology, emphasizing the strong core business growth, potential upsell opportunities, and the cautious approach due to macroeconomic variability.
The dialogue discusses the company's financial growth, AI-driven productivity improvements, and long-term margin targets. The company raised its long-term non-GAAP operating margin target to 30%, driven by disciplined investment in high-return areas and AI productivity gains. It expects to achieve this target within three years. Additionally, the company sees AI and AIC products as key drivers for expanding net new ARR and stabilizing growth across net new logos and expansion.
The dialogue covers the impact of Anthropic's supply chain risk on AI platforms, emphasizing model agnosticism and customer choice. It also discusses the potential for future acquisitions to expand AI capabilities in various verticals. The session concludes with an apology for a technical outage and appreciation for participants.
要点回答
Q:What are the financial results for Uipath's fourth quarter and full year fiscal 2026?
A:Uipath reported fourth quarter ARR at $1.853 billion, up 11% year over year, with revenue of $481 million, up 14% year over year. For the full year, Uipath achieved full year GAAP profitability for the first time, with fourth quarter non-GAAP operating income at $150 million and a 31% margin.
Q:What is the significance of the advancements in AI for software development?
A:Advances in AI are dramatically reducing the time and cost required to create software. This shift changes how value is captured in software development, with enterprises valuing trust, operability, governance, and the ability to run complex systems reliably, securely, and with full accountability.
Q:What are Uipath's four advantages as it enters the new agentic era?
A:Uipath's four advantages for the new agentic era include: 1) A unified platform combining deterministic and AI-driven automation with enterprise-grade orchestration, governance, security, and scalability; 2) A powerful installed base flywheel with opportunities for agent deployment and process orchestration; 3) Decades of trust, governance, and deployment experience; and 4) Deep vertical expertise with horizontal orchestration capabilities across the enterprise.
Q:How does Uipath's platform facilitate the transition from deterministic to AI-driven automation?
A:Uipath's platform allows enterprises to pair insights gained from AI with actions and execution through deterministic and AI-driven automation. This integration helps in institutionalizing complex cross-system processes with accountability and compliance built in.
Q:What does real enterprise orchestration entail according to Uipath?
A:Real enterprise orchestration according to Uipath involves bringing together agentic automation, deterministic automation, and human intervention because that is how work actually gets done. The orchestration governs how a transaction moves from start to finish, ensuring reliable completion every time.
Q:What are the architectural benefits of Maestro, Uipath's workflow technology?
A:Maestro is built on Temporal, the most modern workflow technology featuring durable execution, which allows workflows to be defined in a way that is transparent to business stakeholders and auditors, while being directly modifiable by AI agents. This transparency and modification capability are particularly significant in a world where AI is increasingly creating and maintaining workflows.
Q:How is the Uipath AI product contributing to the company's growth?
A:The Uipath AI product, which includes AI IDP and Maestro, reached nearly $200 million in quarterly ARR with strong growth fueled by automation. The number of customers above $100K in ARR who have bought AI products grew 25% year over year and these customers spent nearly three times as much as those who have not adopted AI products.
Q:What are the expansion opportunities in the testing area for Uipath?
A:Testing is an area where Uipath sees a significant and underappreciated expansion opportunity as the adoption of genetic workflows and application sprawl increases. Traditional QA methods can't keep up with the demand, and Uipath's Test Cloud was recognized as a leader by Forester in multiple criteria, including vision and execution.
Q:How does Uipath's approach to governance and security differentiate in the market?
A:Uipath's approach to governance and security differentiates in the market by providing deterministic execution with traceability, exception handling, and audit trails that satisfy external regulators. This was evident in choices made by an American credit union and a European automobile manufacturer, who chose Uipath for its strict banking security and governance requirements.
Q:What are the implications of the new genetic AI solutions for healthcare?
A:Uipath's new genetic AI solutions are purpose-built for healthcare, targeting revenue cycle management, medical record summarization, claim denial resolution, and prior authorization. This strategy also includes the acquisition of Work Fusion, which brings agents for financial crime compliance with deep anti-money laundering capabilities, enhancing Uipath's reach into the highest stakes compliance workflows inside global banks.
Q:What are the two examples of a broader strategy that combines vertical depth with horizontal reach?
A:The two examples of a broader strategy that combines vertical depth with horizontal reach are healthcare and financial services.
Q:What new capabilities will the next generation of coding agents enable?
A:The next generation of coding agents will enable participation across the entire automation lifecycle, including process discovery and exception identification, definition generation, development assistance, deployment, and runtime management.
Q:What is the new AI capability that will address the issue of growing automation backlogs?
A:The new AI capability that will address the issue of growing automation backlogs is AI coding agents which will generate and maintain production-grade unattended UiPath automations in hours instead of weeks.
Q:What are the priorities for the upcoming fiscal year?
A:The priorities for the upcoming fiscal year are accelerating growth across the customer base, expanding penetration within the installed base, scaling AI adoption atop deterministic automation, deepening the vertical solution strategy in regulated and mission-critical industries, improving the time to value by enhancing coordination among the deployment, services, post-sales teams, and partners, and scaling operating leverage including internal adoption of agentic capabilities and cost discipline.
Q:What is the updated non GAAP operating margin target?
A:The updated non GAAP operating margin target is 25%.
Q:What was the impact of foreign exchange on revenue growth?
A:Foreign exchange had a positive impact on revenue growth, with a year-over-year tailwind of approximately $16 million in the fourth quarter and $30 million for the fiscal year 2026.
Q:What is the significance of AI products' usage among customers?
A:The significance of AI products' usage among customers is that 90% of customers with more than $1 million in ARR are using AI products, and among those with more than $100,000 in ARR, approximately 60% are using AI products. This high level of attachment is described as a retention and expansion flywheel that provides high confidence in the durability of customers.
Q:How has the company's approach to capital allocation been demonstrated?
A:The company's approach to capital allocation has been demonstrated by completing its $1 billion stock repurchase program and authorizing an additional $500 million in repurchase capacity, reflecting confidence in the durability of cash flows and a commitment to disciplined capital allocation.
Q:What is the company's philosophy towards guidance and how is it structured?
A:The company's guidance philosophy remains unchanged, based on what is seen in the pipeline and applying prudent assumptions. The guidance reflects continued momentum across the business and includes the contribution from WorkFusion aligned to the company's ARR definition and work-function that strengthens its position in financial services automation. It also includes the current foreign exchange rates and modest headwinds or tailwinds from specific currencies.
Q:What is the expected non-GAAP adjusted free cash flow for fiscal year 2027?
A:The expected non-GAAP adjusted free cash flow for fiscal year 2027 is approximately $425 million, and it is expected to follow normal seasonal patterns.
Q:How does foreign exchange affect the revenue forecast?
A:The foreign exchange contribution to the revenue forecast is minimal and has a negligible impact on the company's estimates, as it is expected to be immaterial for the full year.
Q:What details can be provided regarding the split between IDP and the agent side concerning the AR figures?
A:The company has experienced great momentum in the diffusion of AI within its platform, but it has not provided clear ratios between different components of the AI. It allows fungibility between its AI and AI products. IDP definitely has a good portion of the ARR, but Genesys is a significant portion and is reflected in the platform, deals, and commentary. The company doesn't materially split it out, but sees them as complements, with IDP including Ixp which is not simple document processing but uses advanced technology to parse different documents.
Q:How should the work fusion contribution be considered when examining the guidance from a net UAR basis?
A:The guidance includes the work fusion contribution, which is significant and impacts the overall strength within the guidance. However, it is considered immaterial and is not broken out separately.
Q:What is the company's view on the federal government and its impact on revenue?
A:The company is seeing good traction with the federal government. Its team has connected at high levels within the organization, and while there are some agencies undergoing changes, the company is very bullish about the opportunities. There is an increased appetite for long-term, strategic projects, especially in the Department of War.
Q:What is the company's positioning in the market for automation and AI, and how does it plan to capture market share?
A:The company is well positioned to help customers with the diffusion of AI within their enterprise workflows. It has West which process orchest technologies with a powerful workflow engine providing a significant advantage in the market. The company is extremely bullish about the adoption curve for AI agents, which will enable the platform for coding agents to accelerate the time to value for customers. This includes the creation and deployment of AI agents in the context of enterprise workflows. The company emphasizes the importance of the combination between deterministic automation and agentic automation on the same platform, which can orchestrate both human thought and deterministic automation.
Q:What is the current environment like for the company, and how are they characterizing it?
A:The current environment is characterized as variable, with pockets of strength and pressure fluctuating due to macroeconomic factors. The company is particularly bullish about the public sector, sees strength in financial services and healthcare, and is aware of the uncertainty due to the Middle East conflict.
Q:What factors are influencing the company's guidance philosophy?
A:The company's guidance philosophy is maintained consistently. They consider their pipeline, gather signals from the field, and utilize strong statistical and forecasting models. They also look at macroeconomic variability and the traction made in the agentic market to determine guidance.
Q:Which industries are showing the strongest willingness to spend on genetic AI initiatives?
A:Healthcare and financial crime are the two verticals showing the strongest willingness to spend on genetic AI initiatives. Within healthcare, parts of revenue cycle management, denial, and prior authorization are highlighted as important processes. The financial industry, particularly since the acquisition of World Fusion, has also shown strong interest, alongside the public sector.
Q:Is Maestro vendor agnostic in terms of managing agents?
A:Maestro is agnostic regarding the type of agents it can manage. It has tight integrations with agents built with its own tools like Agent Builder and also supports agents built with open source frameworks, treating them as first-class citizens. It does not manage third-party system of records applications but facilitates their use within its platform.
Q:How does the SaaS shift impact growth, and is there a timing dynamic that affects revenue?
A:The SaaS shift impacts growth positively, as indicated by the 1% growth contribution in the forecasted year. There is no impact of timing dynamics or consumption related to the logic solutions that would not yet show up in revenue. The company still prices on a consumption basis but reports growth from genetic solutions scaling and customers adopting more, contributing to the SaaS headwind.
Q:What is the significance of the backlog of automations at customers?
A:The growing backlog of automations at customers represents a significant tailwind for AI in unlocking more automatable workflows. This interest in AI is driving renewed interest in automation, with AI initiatives surfacing more opportunities for automation, especially in unattended deterministic automations.
Q:What are the biggest drivers of growth next year?
A:The biggest drivers of growth next year are anticipated to be AI products, with 90% of million-dollar-plus customers incorporating AI products. The AI products are seen as instrumental in driving growth. The company expects synergistic effects, where AI and automation products from them will also drive growth in other parts of the platform.
Q:How is the company’s partner strategy working and can it be scaled up further?
A:The company's partner strategy is resonating well across various verticals, and they are looking to double down on their vertical strategy and increase investment in it in the coming year.
Q:What are the three major pillars of the company's product strategy?
A:The three major pillars of the company's product strategy are: (1) adopting coding agents across the platform, (2) focusing on process orchestration for agentic AI and deterministic workflows, and (3) developing vertical solutions tailored to customers' outcome, vision, and use-case based requirements.
Q:What factors contributed to the company's sales execution and customer traction in AI products?
A:The factors that contributed to the company's sales execution and customer traction in AI products were strong customer responses and the overall momentum within the AI products.
Q:How is the adoption of AI impacting customers' renewal rates and their need for additional automations?
A:The adoption of AI is impacting customers' renewal rates positively as they renew and expand into AI products. It is also making customers more confident in their need for additional automations as they progress through the life cycle of their contracts.
Q:What is the significance of the screenplay agent in driving automation growth within customers?
A:The screenplay agent is significant in driving automation growth as it is used in the context of autonomous workflows. It leverages deterministic UI automation technologies in cases with high screen variability, extending the company's platform into use cases it couldn't previously touch.
Q:How does the company's conservative guidance methodology factor in the effects of overlapping customers and the integration period with newly acquired companies?
A:The company's conservative guidance methodology factors in the effects of overlapping customers and the integration period with newly acquired companies by considering the business growth, utilization, stickiness across the tech and AI platform, and the need for an integration period which is all baked into their guidance.
Q:What is the long-term non GAAP operating margin target, and what factors contribute to the confidence in achieving that target?
A:The long-term non GAAP operating margin target is set at 30%, which is a meaningful step up from the current operating margin. Factors contributing to the confidence in achieving this target include good progress in scalability, operating with discipline, making investments in high return areas, and productivity gains from AI. The company also sees expansion and support for their broader roadmap due to advances in R&D spend, and similar improvements across other functions.
Q:What are the main drivers to consider when looking at dollar-based net revenue retention for fiscal year 2027?
A:The main drivers to consider when looking at dollar-based net revenue retention for fiscal year 2027 are net new ARR stabilizing, the mix shift between net new logos and expansion, and the overall expansion across the customer base, which is being driven by AI and AI products, and deterministic automation.
Q:How should one think about the dollar-based net revenue retention assumptions in the guidance considering the impact of FX?
A:One should consider that the dollar-based net revenue retention assumptions in the guidance are based on the current net new ARR stabilizing and the existing mix of net new logos and expansion, and that the impact of FX is adjusted for.
Q:Has the company seen any impact from Anthropic's supply chain risk designation, and what is the company's strategy regarding model usage?
A:The company has not seen any impact from Anthropic's supply chain risk designation as they have a model-agnostic strategy. They offer Anthropic models but they are optional and not mandatory, ensuring no impact on their working relationship with public agencies in the US regarding their acquisition of Work Fusion.

UiPath, Inc. Class A
Follow





